Intuniv
NDC 54092-513, guanfacine, tablet, extended release, from Takeda Pharmaceuticals America, Inc..
- Product NDC
- 54092-513
- Status
- Listed
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA022037
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/54092-513 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GUANFACINE HYDROCHLORIDE1 mg/1
Pharmacologic classes
Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 54092-513-02 | 54092051302 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (54092-513-02) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/b972af81-3a37-40be-9fe1-3ddf59852528NADAC price for package 54092051302
GET /v1/drugs/nadac/54092051302
Use it
Look up 54092-513 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/54092-513 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 54092-513. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.